期刊
JOURNAL OF CONTROLLED RELEASE
卷 244, 期 -, 页码 83-97出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.11.014
关键词
Site-specific nuclease; Therapeutic gene editing; Non-viral delivery; Viral vectors
资金
- Natural Science Foundation of China [31600686]
- ShanghaiTech University
The advent of site-specific nucleases, particularly CRISPR/Cas9, provides researchers with the unprecedented ability to manipulate genomic sequences. These nucleases are used to create model cell lines, engineer metabolic pathways, produce transgenic animals and plants, perform genome-wide functional screen and, most importantly, treat human diseases that are difficult to tackle by traditional medications. Considerable efforts have been devoted to improving the efficiency and specificity of nucleases for clinical applications. However, safe and efficient delivery methods remain the major obstacle for therapeutic gene editing. In this review, we summarize the recent progress on nuclease delivery methods, highlight their impact on the outcomes of gene editing and discuss the potential of different delivery approaches for therapeutic gene editing. (C) 2016 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据